World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
12921
World Ranking
3048
National Ranking
205

Thomas Hünig publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas Hünig sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 219 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas Hünig D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas Hünig sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas Hünig is affiliated with the University of Würzburg in Germany, focusing on medical research with significant contributions in hematology and oncology. Their research encompasses multiple aspects of hematological malignancies, with a pronounced emphasis on multiple myeloma.

The primary fields of study pursued by Thomas Hünig include:

  • Medicine

Within this broad field, their work is specialized in several subfields:

  • Hematology
  • Oncology
  • Immunology
  • Molecular Biology
  • Immunology and Allergy

The main research topics addressed by Thomas Hünig are:

  • Multiple Myeloma Research and Treatments
  • Cell Adhesion Molecules Research
  • Chemokine receptors and signaling
  • Protein Degradation and Inhibitors
  • T-cell and B-cell Immunology
  • Lymphoma Diagnosis and Treatment
  • Peptidase Inhibition and Analysis

Their publication record reflects a focus on multiple myeloma and related hematologic diseases, with papers appearing in journals such as Haematologica, Leukemia, Blood Advances, British Journal of Haematology, and Clinical and Experimental Medicine. Notable recent papers include:

  • Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression, 2020, Haematologica
  • Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression, 2021, Leukemia
  • Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans, 2021, Blood Advances
  • Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma, 2022, British Journal of Haematology
  • STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure, 2023, Clinical and Experimental Medicine

Thomas Hünig has regularly published in certain clinical journals, most frequently in:

  • Clinical Lymphoma Myeloma & Leukemia
  • Blood
  • Haematologica
  • Leukemia
  • Clinical and Experimental Medicine

Collaborations have been a consistent aspect of their research, with frequent co-authors including:

  • Andreas Beilhack
  • Hermann Einsele
  • Leo Rasche
  • Antonio Giovanni Solimando
  • K. Martin Kortüm

Best Publications

  • Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

    Hubert Schorle;Thomas Holtschke;Thomas Hünig;Anneliese Schimpl

  • A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes.

    T Hünig;H J Wallny;J K Hartley;A Lawetzky

  • Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand

    T. Hünig;G. Tiefenthaler;K.-H. Meyer zum Büschenfelde;S. C. Meuer

  • A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.

    Magdalena Huber;Sylvia Heink;Henrike Grothe;Anna Guralnik

  • Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist

    Chia-Huey Lin;Thomas Hünig

  • The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules

    Thomas Kerkau;Igor Bacik;Jack R. Bennink;Jonathan W. Yewdell

  • Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms.

    Martina Wolf;Anneliese Schimpl;Thomas Hünig

  • Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis

    Niklas Beyersdorf;Stefanie Gaupp;Karen Balbach;Jens Schmidt

  • Topological Requirements and Signaling Properties of T Cell–activating, Anti-CD28 Antibody Superagonists

    Fred Lühder;Yun Huang;Kevin M. Dennehy;Christine Guntermann

  • CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28

    Michael Tacke;Gabriele Hanke;Thomas Hanke;Thomas Hünig

  • Regulatory T Cells Protect from Local and Systemic Bone Destruction in Arthritis

    Mario M. Zaiss;Benjamin Frey;Andreas Hess;Jochen Zwerina

  • Crystal structure of a soluble CD28-Fab complex

    E J Evans;R M Esnouf;R Manso-Sancho;Gilbert Rjc.

  • IMMUNOPATHOLOGY OF INTERLEUKIN (IL) 2-DEFICIENT MICE : THYMUS DEPENDENCE AND SUPPRESSION BY THYMUS-DEPENDENT CELLS WITH AN INTACT IL-2 GENE

    Susanne Kramer;Anneliese Schimpl;Thomas Hunig

  • Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412

    Paula S. Römer;Susanne Berr;Elita Avota;Shin Young Na

  • Specificity of cytotoxic T cells from athymic mice.

    T Hünig;M J Bevan

  • Differential thymus dependence of rat CD8 isoform expression.

    Nora Torres-Nagel;Elmar Kraus;Marion H. Brown;Georg Tiefenthaler

  • Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo.

    Marta Rodríguez-Palmero;Toyomichi Hara;Alexander Thumbs;Thomas Hünig

  • CD28 co-stimulation in T-cell homeostasis: a recent perspective

    Niklas Beyersdorf;Thomas Kerkau;Thomas Hünig

  • IL-2 and autoimmune disease.

    Anneliese Schimpl;Ingolf Berberich;Burkhardt Kneitz;Susanne Krämer

  • The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody.

    Thomas Hunig

Frequent Co-Authors

Fred Lühder
Fred Lühder University of Göttingen
Klaus V. Toyka
Klaus V. Toyka University of Würzburg
Hermann Einsele
Hermann Einsele University of Würzburg
Ralf Gold
Ralf Gold Ruhr University Bochum
Georg Stingl
Georg Stingl Medical University of Vienna
Ivan D. Horak
Ivan D. Horak Freie Universität Berlin
Peter F. Zipfel
Peter F. Zipfel Friedrich Schiller University Jena
Timothy A. Springer
Timothy A. Springer Boston Children's Hospital
Michael L. Dustin
Michael L. Dustin University of Oxford
Lars Nitschke
Lars Nitschke University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Those seeking to specialize in mental health nursing might consider programs like the cheapest online pmhnp programs. These affordable options help professionals gain expertise in psychiatric care, complementing immunological knowledge when addressing neuroimmune disorders.

Nurse Practitioners (NPs) with a background in immunology can boost their earning potential by focusing on specialties with high demand. According to data on highest paid dnp specialties, acute care and specialty nursing roles tend to offer some of the best compensation, making them attractive options for advanced practice nurses.

If you are already a Family Nurse Practitioner (FNP) and want to work more closely with patients requiring immunological expertise, pursuing an acute care certification for fnp can be a strategic career move. This certification enables you to manage complex health conditions where immune function is critical.

For those looking to fast-track their education, multiple accelerated np programs offer flexible online formats designed to quickly prepare students for Nurse Practitioner roles in various specialties, including immunology-related fields. These programs provide an efficient pathway to enter the workforce and impact patient care.

Best Scientists Citing Thomas Hünig

Trending Scientists

Recently Published Articles